Bipartisan group of senators asks FDA to examine drug shortages

FDA Commissioner Scott Gottlieb, MD, is being urged to give Congress recommendations on how deal with drug shortages across the United States. A bipartisan group of senators, led by Sens.

FDA Commissioner Scott Gottlieb, MD, is being urged to give Congress recommendations on how deal with drug shortages across the United States. A bipartisan group of senators, led by Sens. Chris Murphy (D-CT) and Bill Cassidy (R-LA), has called on FDA to have a task force investigate the cause of the shortages and develop policy recommendations on how to resolve the issues before year-end 2019. A letter sent to Gottlieb by Murphy, Cassidy, and 29 of their colleagues noted in particular shortages of some routinely used medicines, including local anesthetics and sterile I.V. fluids. "These are essential products used every day, and for many of them there are no suitable alternatives that are readily available," the senators said. "This can result in suboptimal pain control or sedation for patients, and ultimately limit patient access to the most appropriate care."